Fundraising Fox
/Companies
Sign in

Clinipace

Morrisville, US · Delaware corporation · 3 known investors

Find your way into Clinipace

Sign up to find every way you can get introduced to Clinipace

  • Your email: who you already know at Clinipace, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Clinipace team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials. It focuses on managing complex trials and delivering clinical data to support decision-making for drug developers.

BiotechDigital HealthHealthtech

Founders & leadership

MU
Mark UbertExecutive
JW
Jesse WatsonNamed on SEC filing
BC
Brian CarneyNamed on SEC filing
JL
Jeff L. WilliamsNamed on SEC filing
MD
Melissa DanielsNamed on SEC filing
CK
Christopher K. PorterNamed on SEC filing
JM
Jeremy MarioNamed on SEC filing
GR
Gena ReedNamed on SEC filing
DF
David FitzgeraldNamed on SEC filing

Board

KL
Ken LeeBoard director
JCJohn Crumpler
John CrumplerBoard directorGeneral Partner at Hatteras Venture Partners
JG
Julia GregoryBoard director

Investors · 3

Hatteras Venture Partnerslisted by Hatteras Venture PartnersResearch Triangle · $500K – $4M

How we know: Hatteras Venture Partners's portfolio page · a partner's Signal profile · funding news · Not right? Tell us

OUP (Osage University Partners)listed by OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

How we know: OUP (Osage University Partners)'s portfolio page · a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$76.2M disclosed across 12 of 13 rounds · 2014–2021

▶$4.1MraisedOct 2020 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Melissa DanielsDirector
  • Jeremy MarioDirector
  • David FitzgeraldDirector
  • Jesse WatsonDirector
  • Steve SkolskyDirector
  • Steven ListDirector
  • Jason MonteleoneExecutive Officer, Director
Offering amount
$10M
Amount sold
$4.1M
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.7MraisedFeb 2020 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeremy MarioDirector
  • Jason MonteleoneExecutive Officer, Director
  • Melissa DanielsDirector
  • Chris SempleDirector
  • David FitzgeraldDirector
  • Jesse WatsonDirector
  • Steve SkolskyDirector
Offering amount
$14.7M
Amount sold
$14.7M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedAug 2019 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris SempleDirector
  • Jesse WatsonDirector
  • Steve SkolskyDirector
  • Jason MonteleoneExecutive Officer, Director
  • Melissa DanielsDirector
  • Jeremy MarioDirector
  • David FitzgeraldDirector
Offering amount
$3.8M
Amount sold
$3.8M
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedMar 2019 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jesse WatsonDirector
  • David FitzgeraldDirector
  • Steve SkolskyDirector
  • Jason MonteleoneExecutive Officer, Director
  • Melissa DanielsDirector
  • Jeremy MarioDirector
  • Chris SempleDirector
Offering amount
$4M
Amount sold
$4M
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedSep 2018 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason MonteleoneExecutive Officer, Director
  • Jeremy MarioDirector
  • Jesse WatsonDirector
  • David FitzgeraldDirector
  • Steve SkolskyDirector
  • Melissa DanielsDirector
  • Chris SempleDirector
Offering amount
$5.7M
Amount sold
$5.7M
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedDec 2017 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeremy MarioDirector
  • Jason MonteleoneExecutive Officer, Director
  • Steve SkolskyDirector
  • Jesse WatsonDirector
  • David FitzgeraldDirector
  • Melissa DanielsDirector
  • Chris SempleDirector
Offering amount
$20M
Amount sold
$10M
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedNov 2017 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff WilliamsDirector
  • Melissa DanielsDirector
  • Jeremy MarioDirector
  • Gena ReedDirector
  • Ken LeeDirector
  • Jason MonteleoneExecutive Officer
  • David FitzgeraldDirector
  • Steve SkolskyDirector
  • Jesse WatsonDirector
  • Brian CarneyDirector
Offering amount
$3M
Amount sold
$3M
First sale
Nov 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.7MraisedJul 2016 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark UbertExecutive Officer
  • Ken LeeDirector
  • Jesse WatsonDirector
  • Brian CarneyDirector
  • Jeff L. WilliamsExecutive Officer, Director
  • Melissa DanielsDirector
  • Christopher K. PorterExecutive Officer
  • Jeremy MarioDirector
  • Gena ReedDirector
  • David FitzgeraldDirector
Offering amount
$4.3M
Amount sold
$3.7M
First sale
Jul 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Clinipace do?
Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials. It focuses on managing complex trials and delivering clinical data to support decision-making for drug developers.
Who are Clinipace's investors?
Clinipace's investors include Creathor Ventures, Hatteras Venture Partners, OUP (Osage University Partners).
How much funding has Clinipace raised?
Clinipace has disclosed $76.2M raised across 12 of its 13 known rounds.
Where is Clinipace headquartered?
Clinipace is headquartered in Morrisville, US.